The hepatic levels of MDA were significantly reduced, while those of GSH, HO-1, and SOD were significantly increased, in the control + SFFE- and T2DM + SFFE-treated rats, as compared to their corresponding controls (i.e., control and T2DM rats, respectively) (Figure 3A–D). The gene discussed is SOD1; the disease is type 2 diabetes mellitus.